PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental Immunology and.\', \'Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.\', \'Cancer Center Amsterdam, Amsterdam, The Netherlands.\', \'Amsterdam Institute for Infection & Immunity, Amsterdam, The Netherlands; and.\', \'Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1182/bloodadvances.2020003768
?:hasPublicationType
?:journal
  • Blood advances
is ?:pmid of
?:pmid
?:pmid
  • 33560402
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33560402>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33560402>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all